7.14 USD
↗ 0.09 (1.28%)AT CLOSE (11:59 AM EDT)
Clene Inc. Common Stock
CLNNNASDAQ • USD
7.12
↘ 0.02 (0.25%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
7.12
↘ 0.02 (0.25%)
Market: CLOSED
Open?$6.79
High?$7.37
Low?$6.71
Prev. Close?$7.05
Volume?151.6K
Avg. Volume?921.9K
VWAP?$7.02
Rel. Volume?0.16x
Bid / Ask
Bid?$5.89 × 100
Ask?$8.33 × 100
Spread?$2.44
Midpoint?$7.11
Valuation & Ratios
Market Cap?91.2M
Shares Out?11.8M
Float?8.3M
Float %?70.3%
P/E Ratio?N/A
P/B Ratio?-4.85
EPS?-$2.62
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Themes
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50
SALT LAKE CITY, UT 84121
Phone: 801-676-9695
SALT LAKE CITY, UT 84121
Phone: 801-676-9695
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.94Adequate
Quick Ratio?1.93Adequate
Cash Ratio?0.88Adequate
Debt/Equity?-0.97Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?-4.85CHEAP▾
P/S?680.87HIGH▾
P/FCF?N/A▾
EV/EBITDA?-5.3CHEAP▾
EV/Sales?772.41HIGH▾
Returns & Efficiency
ROE?177.9%STRONG▾
ROA?-154.4%WEAK▾
Cash Flow & Enterprise
FCF?$-18102000
Enterprise Value?$103.5M
Fundamentals ratios updated end of day